A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.

NCT00645437 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Diseases

Interventions

DRUG: Levofloxacin

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.